← Back to Company DatabaseVisit Website
Sophia Genetics
AI-powered data analytics for genomics-driven cancer care.
PublicLausanne, SwitzerlandFounded 2011
About
SOPHiA GENETICS provides a cloud-based AI platform that analyzes genomic and radiomic data to support clinical decisions in oncology. The SOPHiA DDM platform is used by hospitals worldwide to interpret genomic variants and guide precision cancer treatment. The company connects a global network of healthcare institutions to share knowledge and improve patient outcomes.
Total Funding
$260MKey Product
SOPHiA DDM genomic analytics platformGeography
EuropeKey Investors
Generation Investment ManagementBalderton CapitalAlychlo
Focus Areas
Data / AnalyticsDiagnosticsAI / Machine Learning
Technology
AI / Machine LearningGenomics / SequencingDigital Health / Software
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026